Cart

“Number Needed to Treat to Harm for Discontinuation Due to Adverse Events in the Treatment of Bipolar Depression, Major Depressive Disorder, and Generalized Anxiety Disorder With Atypical Antipsychotics PDF” has been added to your cart. View cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item	Product	Price	Quantity	Subtotal
×	Prescribing of Z-Drugs With and Without Opioid Coprescribing to Primary Care Patients in a Large Health Care System From 2019–2020 PDF	$40.00	Prescribing of Z-Drugs With and Without Opioid Coprescribing to Primary Care Patients in a Large Health Care System From 2019–2020 PDF quantity	$40.00
×	Response to Past Depression Treatments Is Not Accurately Recalled: Comparison of Structured Recall and Patient Health Questionnaire Scores in Medical Records PDF	$40.00	Response to Past Depression Treatments Is Not Accurately Recalled: Comparison of Structured Recall and Patient Health Questionnaire Scores in Medical Records PDF quantity	$40.00
×	A Case and Proposed Mechanism of Catatonia During the Post-Acute Phase of Severe Acute Respiratory Syndrome Coronavirus 2 Infection PDF	$40.00	A Case and Proposed Mechanism of Catatonia During the Post-Acute Phase of Severe Acute Respiratory Syndrome Coronavirus 2 Infection PDF quantity	$40.00
×	Psychiatric Care of the Patient With Hepatitis C: A Review of the Literature PDF	$40.00	Psychiatric Care of the Patient With Hepatitis C: A Review of the Literature PDF quantity	$40.00
×	Responses to the Medical Review of Systems: Borderline Versus Nonborderline Patients in an Internal Medicine Outpatient Clinic PDF	$40.00	Responses to the Medical Review of Systems: Borderline Versus Nonborderline Patients in an Internal Medicine Outpatient Clinic PDF quantity	$40.00
×	Trends in Receipt of Mental Health Treatments Among Adults in the United States, 2008-2013 PDF	$40.00	Trends in Receipt of Mental Health Treatments Among Adults in the United States, 2008-2013 PDF quantity	$40.00
×	Prevalence of Psychiatric Disorders Among Children and Adolescents in Child Welfare Custody Admitted to the Hospital: A Nationwide Inpatient Sample Analysis PDF	$40.00	Prevalence of Psychiatric Disorders Among Children and Adolescents in Child Welfare Custody Admitted to the Hospital: A Nationwide Inpatient Sample Analysis PDF quantity	$40.00
×	A 6-Month Follow-Up Study of Posttraumatic Stress and Anxiety/Depressive Symptoms in Korean Children After Direct or Indirect Exposure to a Single Incident of Trauma PDF	$40.00	A 6-Month Follow-Up Study of Posttraumatic Stress and Anxiety/Depressive Symptoms in Korean Children After Direct or Indirect Exposure to a Single Incident of Trauma PDF quantity	$40.00
×	Efficacy and Safety of the α7-Nicotinic Acetylcholine Receptor Agonist ABT-126 in the Treatment of Cognitive Impairment Associated With Schizophrenia: Results From a Phase 2b Randomized Controlled Study in Smokers PDF	$40.00	Efficacy and Safety of the α7-Nicotinic Acetylcholine Receptor Agonist ABT-126 in the Treatment of Cognitive Impairment Associated With Schizophrenia: Results From a Phase 2b Randomized Controlled Study in Smokers PDF quantity	$40.00
×	Current Approaches to the Recognition and Treatment of Alcohol Withdrawal and Delirium Tremens: "Old Wine in New Bottles" or "New Wine in Old Bottles" PDF	$40.00	Current Approaches to the Recognition and Treatment of Alcohol Withdrawal and Delirium Tremens: "Old Wine in New Bottles" or "New Wine in Old Bottles" PDF quantity	$40.00
×	An Observational Study Comparing the Safety and Efficacy of Conventional Anticoagulation Versus New Oral Anticoagulants in the Management of Cerebral Venous Sinus Thrombosis PDF	$40.00	An Observational Study Comparing the Safety and Efficacy of Conventional Anticoagulation Versus New Oral Anticoagulants in the Management of Cerebral Venous Sinus Thrombosis PDF quantity	$40.00
×	Safety and Feasibility of Repetitive Transcranial Magnetic Stimulation in the Treatment of Anxious Depression in Pregnancy: A Case Report PDF	$40.00	Safety and Feasibility of Repetitive Transcranial Magnetic Stimulation in the Treatment of Anxious Depression in Pregnancy: A Case Report PDF quantity	$40.00
×	High-Dose Citalopram and Escitalopram and the Risk of Out-of-Hospital Death PDF	$40.00	High-Dose Citalopram and Escitalopram and the Risk of Out-of-Hospital Death PDF quantity	$40.00
×	Elevated Hemoglobin A1c as a Possible Indicator of Diabetes Mellitus and Diabetic Ketoacidosis in Schizophrenia Patients Receiving Atypical Antipsychotics PDF	$40.00	Elevated Hemoglobin A1c as a Possible Indicator of Diabetes Mellitus and Diabetic Ketoacidosis in Schizophrenia Patients Receiving Atypical Antipsychotics PDF quantity	$40.00
×	Neurocognitive Impairment and Psychosis in Bipolar I Disorder During Early Remission From an Acute Episode of Mood Disturbance PDF	$40.00	Neurocognitive Impairment and Psychosis in Bipolar I Disorder During Early Remission From an Acute Episode of Mood Disturbance PDF quantity	$40.00
×	Response and Relapse in Patients With Schizophrenia Treated With Olanzapine, Risperidone, Quetiapine, or Haloperidol: 12-Month Follow-Up of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) Study PDF	$40.00	Response and Relapse in Patients With Schizophrenia Treated With Olanzapine, Risperidone, Quetiapine, or Haloperidol: 12-Month Follow-Up of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) Study PDF quantity	$40.00
×	Prediction of Placebo Response in 2 Clinical Trials of Lisdexamfetamine Dimesylate for the Treatment of ADHD PDF	$40.00	Prediction of Placebo Response in 2 Clinical Trials of Lisdexamfetamine Dimesylate for the Treatment of ADHD PDF quantity	$40.00
×	A Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Selegiline Transdermal System Without Dietary Restrictions in Patients With Major Depressive Disorder PDF	$40.00	A Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Selegiline Transdermal System Without Dietary Restrictions in Patients With Major Depressive Disorder PDF quantity	$40.00
×	Efficacy of Quetiapine Monotherapy for the Treatment of Depressive Episodes in Bipolar I Disorder: A Post Hoc Analysis of Combined Results From 2 Double-Blind, Randomized, Placebo-Controlled Studies PDF	$40.00	Efficacy of Quetiapine Monotherapy for the Treatment of Depressive Episodes in Bipolar I Disorder: A Post Hoc Analysis of Combined Results From 2 Double-Blind, Randomized, Placebo-Controlled Studies PDF quantity	$40.00
×	Combined Total Sleep Deprivation and Light Therapy in the Treatment of Drug-Resistant Bipolar Depression: Acute Response and Long-Term Remission Rates. PDF	$40.00	Combined Total Sleep Deprivation and Light Therapy in the Treatment of Drug-Resistant Bipolar Depression: Acute Response and Long-Term Remission Rates. PDF quantity	$40.00
×	Number Needed to Treat to Harm for Discontinuation Due to Adverse Events in the Treatment of Bipolar Depression, Major Depressive Disorder, and Generalized Anxiety Disorder With Atypical Antipsychotics PDF	$40.00	Number Needed to Treat to Harm for Discontinuation Due to Adverse Events in the Treatment of Bipolar Depression, Major Depressive Disorder, and Generalized Anxiety Disorder With Atypical Antipsychotics PDF quantity	$40.00
Coupon:

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.

Join Now

Cart totals

Subtotal	$840.00
Total	$840.00

Proceed to checkout

Cart

Cart totals

ELSEWHERE:

FOLLOW US:

Cart

Cart totals

Consensus Report on XT Use in Practice

Subscribe to readmore articles

Subscribe to read
more articles